Clinical trial
A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate…
NCT00403949 · LEO Pharma, Industry · Completed
Key facts
| NCT number | NCT00403949 |
|---|---|
| Title | A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis |
| Official title | A 6-week, Vehicle-controlled, Randomized, Double-blind, Parallel-group Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Perioral Dermatitis |
| Lead sponsor | LEO Pharma, Industry |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Perioral Dermatitis |
| Intervention type | Drug |
| Interventions | Azelaic acid 15% gel, Non-active base from azelaic acid 15% gel |
| Enrollment | 48 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Nov 27, 2006 |
| Last update posted | Jun 9, 2023 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: